SPMD - ETF AI Analysis
Top Page
SPDR Portfolio S&P 400 Mid Cap ETF (SPMD)
SPMD, the SPDR Portfolio S&P 400 Mid Cap ETF, has a solid overall rating driven mainly by strong, growing companies like Permian Resources and TechnipFMC, which show robust financial performance, positive outlooks, and supportive technical trends. Other key holdings such as United Therapeutics and ATI also add strength through solid earnings and growth prospects, though valuation concerns, occasional overbought or bearish technical signals, and company-specific risks like high leverage or regulatory uncertainty in names such as XPO and Okta slightly temper the fund’s appeal. The main risk factor is exposure to several holdings with higher valuations and mixed technical momentum, which could increase volatility if market conditions turn less favorable.
SPMD vs. SPDR S&P 500 ETF (SPY)
- AUM
- 18.84B
- Region
- North America
- Expense Ratio
- 0.03%
- Beta
- 0.89
- Issuer
- SPDR
- Inception Date
- Nov 08, 2005
- Dividend Yield
- 1.29%
- Asset Class
- Equity
- Index Tracked
- S&P Mid Cap 400
SPMD Summary
SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) is a fund that follows the S&P MidCap 400 Index, focusing on medium-sized U.S. companies. These businesses are generally past the risky start-up phase but still have room to grow. The ETF spreads your money across many sectors, including industrials, technology, and health care, and holds well-known names like Okta and Roku. Investors might choose SPMD to diversify their portfolio and tap into potential long-term growth from mid-sized companies. A key risk is that mid-cap stocks can be more volatile than large, established companies and will rise and fall with the overall stock market.
How much will it cost me?
This ETF has an expense ratio of 0.03%, which means you’ll pay about $0.30 per year for every $1,000 invested. That’s lower than the average ETF because it’s a passively managed fund that simply tracks the S&P MidCap 400 Index instead of paying managers to pick individual stocks.
What would affect this ETF?
SPMD could benefit if the U.S. economy grows steadily, as mid-sized companies in sectors like industrials, technology, and financials often see rising profits and stock prices in a healthy business environment. On the downside, higher interest rates, an economic slowdown in the U.S., or sector-specific challenges in areas like health care and consumer cyclical businesses could hurt these mid-cap companies and weigh on the ETF’s future performance.
SPMD Top 10 Holdings
SPMD is leaning into U.S. mid-cap growth, with a noticeable tilt toward industrials, energy, and tech. Rising names like Okta and Entegris give the fund a tech-powered engine, while Permian Resources and TechnipFMC add momentum from the energy patch. United Therapeutics has been steadily pulling its weight from the health care side. On the flip side, ATI and nVent Electric have been lagging lately, acting as mild speed bumps rather than full-on roadblocks. Overall, performance is driven by a diverse mix of U.S. mid-cap workhorses rather than a single star.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 OKTA | Okta | 0.89% | $167.34M | $32.32B | 119.67% | 75Outperform |
 FTI | TechnipFMC | 0.76% | $142.89M | $26.00B | 54.09% | 80Outperform |
 UTHR | United Therapeutics | 0.74% | $139.31M | $25.57B | 39.14% | 79Outperform |
 ENTG | Entegris | 0.67% | $126.18M | $23.16B | 65.24% | 66Neutral |
 ATI | ATI | 0.69% | $129.39M | $23.68B | 86.51% | 78Outperform |
 USFD | US Foods Holding | 0.66% | $124.72M | $22.89B | 49.79% | 74Outperform |
 RS | Reliance Steel | 0.66% | $124.66M | $22.83B | 60.25% | 74Outperform |
 XPO | XPO | 0.65% | $122.32M | $22.34B | 33.70% | 70Outperform |
 THC | Tenet Healthcare | 0.63% | $117.97M | $21.40B | 40.69% | 74Outperform |
 PR | Permian Resources | 0.60% | $112.09M | $20.57B | 80.74% | 81Outperform |
SPMD Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPMD, the sentiment is Positive. The current price of 65.34 is above the 20-day moving average (MA) of 64.05, above the 50-day MA of 64.49, and above the 200-day MA of 63.71, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 56.08 is Neutral, neither overbought nor oversold. The STOCH value of 69.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPMD.
SPMD Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| SPMD | $65.34 | $72.00(10.19% Upside) | $18.84B | 0.03% | 71Outperform |
 IJH | $74.59 | $91.61(22.82% Upside) | $124.27B | 0.05% | 73Outperform |
 VO | $82.37 | $97.98(18.95% Upside) | $107.68B | 0.03% | 69Neutral |
 IWR | $111.56 | $131.41(17.79% Upside) | $58.16B | 0.18% | 68Neutral |
 MDY | $680.30 | $827.93(21.70% Upside) | $26.10B | 0.23% | 70Outperform |
 IVOO | $126.21 | $156.73(24.18% Upside) | $3.93B | 0.07% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SPMD | SPDR Portfolio S&P 400 Mid Cap ETF | 65.34 | 9.86 | 17.77% | |
| IJH | iShares Core S&P Mid-Cap ETF | 74.59 | 11.25 | 17.76% | |
| VO | Vanguard Mid-Cap ETF | 82.37 | 11.82 | 16.75% | |
| IWR | iShares Russell Midcap ETF | 111.56 | 18.37 | 19.71% | |
| MDY | State Street Spdr S&P Midcap 400 Etf Trust | 680.30 | 100.67 | 17.37% | |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 126.21 | 18.96 | 17.68% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.